Elaprase Solution, Concentrate
Product Images NDC 54092-700

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Elaprase (NDC 54092-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (6 mg/3 mL Vial Carton)

ELAPRASE® is a medication used for intravenous infusion which is provided in single-use vials containing 6mg/3mL (2mg/mL) of idursulfase injection. This medication must be diluted before use and the unused portion should be discarded. The medication is registered under the trademark of Shire Human Genetic Therapies, Inc in the USA and Takeda Pharmaceuticals is licensed to sell it. For more information on the medication, dosage, and ingredients, check the package insert. The medication must be stored at 2°-8°C (36°-46°F), should not be frozen or shaken and must be protected from light. The NDC for this product is 54092-700-01 and the GTIN is 0035409270011.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.